The veteran's fungal dermatitis and ichthyosis vulgaris are currently controlled by topical medication, affecting less than 5% of the total body surface area. The Board finds that these conditions do not meet or approximate the requirements for a compensable rating.
The deciding factor: The current level of disability does not meet the criteria for a compensable evaluation under any applicable diagnostic codes due to lack of active disease process and controlled by topical medication.
- Claimed conditions
- fungal dermatitis, ichthyosis vulgaris
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- November 25, 2008
- Citation
- 0840757
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Search VA.gov for the original decision (opens in a new tab) using citation 0840757.
What this means for you
A final Board denial may be appealed to the U.S. Court of Appeals for Veterans Claims, generally within 120 days of the Board mailing date. A Supplemental Claim with new and relevant evidence is a separate option. Another Higher-Level Review of the Board decision is not available. Check your own notice: this historical decision does not set your deadline.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Dismissed
The veteran withdrew their appeals for increased ratings for fungal dermatitis and tension headaches, as well as entitlement to special monthly compensation (SMC). The Board dismissed these appeals.
- Whole decision: Remanded (sent back)
The Veteran's prostate cancer with insomnia is rated at 20 percent from February 22, 2019, to August 10, 2022, and 20 percent after that date. The issues of service connection for ED and loss of use of a creative organ are remanded.,The effective dates for the prostate cancer rating and SMC based on loss of use of a creative organ are denied as they predate February 22, 2019.
- Whole decision: Granted
The Veteran's ichthyosis vulgaris is already rated at the maximum schedular rating, and a TDIU was granted for the period prior to September 20, 2018.
- Whole decision: Remanded (sent back)
The Veteran's skin condition, including ichthyosis vulgaris and dyshidrotic eczema, is rated as noncompensable. The Board has ordered a new examination to determine the severity of his service-connected conditions due to insufficient information about flare-ups.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information. How we handle your email.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.